Carbetimer: A re-evaluation of a drug with a novel mechanism of action

Author:

Ardalan Bach,Hussein Atif M.,Shanahan William R.,Shields Michael J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference51 articles.

1. Mechanism of action of a new antitumor agent, carbetimer;Ardalan;Cancer Res.,1986

2. The tissue distribution of radioactivity in rats following single intravenous and multiple oral administration of 14C-N-137;Cameron;IRI Project No. 115747, Report No. 18325,1980

3. The pharmacokinetics of 14C-labelled N-137 in the dog;Cameron;Invcrsek Research International (IRI) Project No. 115637, Report No. 1832,1980

4. The absorption, distribution and elimination of radioactivity following parenteral and oral administration of 14C-NED-137 to rats;Cameron;IRI Project No. 113053, Report No. 15090,1979

5. The effect of carbetimer (N-137) on clonogenic growth of primary tumor stem cells;Daniels;Int. J. Cell Cloning,1983

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3